FDA Cosmetics Update: 2013 AE Reports Tallied, 2014 Research Targeted

 
• By Katie Saunders

FDA says cosmetic-related adverse events were down in fiscal 2013, but suggests the decline may be due to a falloff in agency outreach and lower consumer awareness. The agency is focused on trace contaminants, with guidance in the works on lipstick lead, and aims to release its final guidance on cosmetic nanomaterials in the coming months, according to Linda Katz, director of FDA’s cosmetics office.

Cosmetic adverse events were down in fiscal 2013 from the year before, but FDA will continue efforts to boost awareness and voluntary reporting while potentially zeroing in on ingredients cited in AE reports, the agency’s cosmetics head indicated Feb. 20.

Speaking at the American Conference Institute’s Legal, Regulatory and Compliance Forum on Cosmetics in New York, Linda Katz, director of FDA’s Office of Cosmetics and Colors, said the agency received 281 reports of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from HBW Insight